atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

Company Overview - atai Life Sciences is a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders [2] - The company was founded to address the significant unmet need and lack of innovation in the mental health treatment landscape [2] - atai is dedicated to developing novel, evidence-based therapeutics for conditions such as depression and anxiety [2] Upcoming Events - The management team of atai is scheduled to participate in the TD Cowen 45th Annual Health Care Conference in Boston, MA from March 3-5, 2025 [1] - The format of participation includes a fireside chat and one-on-one investor meetings, with the fireside chat set for March 3 at 11:50 A.M. ET [1] - An archived replay of the fireside chat will be available on the company's website for up to 90 days [1]